Research by Joel Cantor et al. “Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study”

April 17, 2023

Abstract

Despite effective antiviral therapy for hepatitis C virus (HCV), people who are incarcerated and those returning to the community face challenges in obtaining HCV treatment. We aimed to explore facilitators and barriers to HCV treatment during and after incarceration. From July–November 2020 and June–July 2021, we conducted 27 semi-structured interviews with residents who were formerly incarcerated in jail or prison. The interviews were audio-recorded and professionally transcribed. We used descriptive statistics to characterize the study sample and analyzed qualitative data thematically using an iterative process. Participants included five women and 22 men who self-identified as White (n = 14), Latinx (n = 8), and Black (n = 5). During incarceration, a key facilitator was having sufficient time to complete HCV treatment, and the corresponding barrier was delaying treatment initiation. After incarceration, a key facilitator was connecting with reentry programs (e.g., halfway house or rehabilitation program) that coordinated the treatment logistics and provided support with culturally sensitive staff. Barriers included a lack of insurance coverage and higher-ranking priorities (e.g., managing more immediate reentry challenges such as other comorbidities, employment, housing, and legal issues), low perceived risk of harm related to HCV, and active substance use. Incarceration and reentry pose distinct facilitators and challenges to accessing HCV treatment. These findings signal the need for interventions to improve engagement in HCV care both during and after incarceration to assist in closing the gap of untreated people living with HCV.

Keywords: HCV; Hepatitis C; treatment; direct-acting antiviral DAA; prison; jail; incarceration; linkage to care; qualitative

Citation

Kamat, Samir, Sankeerth Kondapalli, Shumayl Syed, Gabrielle Price, George Danias, Ksenia Gorbenko, Joel Cantor, Pamela Valera, Aakash K. Shah, and Matthew J. Akiyama. 2023. “Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study” Life 13, no. 4: 1033. https://doi.org/10.3390/life13041033

Recent Posts

MCRP student receives 9/11 Memorial Program fellowship

The New York Metropolitan Transportation Council (NYMTC) / Center for Advanced Infrastructure and Transportation (CAIT) September 11th Memorial Program for Regional Transportation Planning selection committee has selected Abigail Alvarez, PPP '25/MCRP '26 for...

Kumar, Andrews: Energy Efficiency Policies in Transition

Reflections on Energy Efficiency Policies in Sustainable Transition: Bedrock, Gamechanger, or More of the Same? Abstract In this study, we analyze how energy efficiency actions, policies, and outcomes are tied to wider socio-economic and political contexts that are...

Studio: Decarbonizing NYC’s Low-to-Moderate-Income Buildings

Read Report Executive Summary Background Commercial and residential buildings are responsible for over 70% of NYC’s greenhouse gas (GHG) emissions (City of New York, 2024). To address the large impact of buildings on climate, New York City’s Local Law 97 (LL97)...

Social Determinants, Health Policy, & Public Health

Social Determinants, Health Policy, and the Public Health Classroom: A Discussion with Katie Pincura Dean Stuart Shapiro and the EJB Talks podcast have returned for season 13 with associate teaching professor Katie Pincura. Katie’s path into public health began as a...